Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

Zsiros, J; Maibach, R; Shafford, E; Brugieres, L; Brock, P; Czauderna, P; Roebuck, D; Childs, M; Zimmermann, A; Laithier, V; Otte, J. B; Camargo, B; MacKinlay, G; Scopinaro, M; Aronson, D; Plaschkes, J; Perilongo, G.
Am J Clin Oncol ; 28(15): 6-10, 2010.
Artículo en Inglés | TXTC | ID: txt-25669

Documentos relacionados

  1. Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement.
  2. [Treatment outcome of 100 patients with hepatoblastoma based on a new risk stratification].
  3. Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma.
  4. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.
  5. Repeat hepatectomy for pediatric recurrent chemotherapy-resistant hepatoblastoma: a report of 18 cases.
  6. Avoiding liver transplantation in post-treatment extent of disease III and IV hepatoblastoma.
  7. A rare case report of extrahepatic hepatoblastoma in a child.
  8. Incidence and long-term outcomes of surgically treated childhood hepatic malignancies in Finland.
  9. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
  10. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.